original ) (raw )Improved purification and biologic activities of staphylococcal toxic shock syndrome toxin 1
Raymond See
Journal of Clinical Microbiology, 1993
View PDFchevron_right
Inhibition of Staphylococcal Enterotoxin A–Induced Superantigenic and Lethal Activities by a Monoclonal Antibody to Toxic Shock Syndrome Toxin–1
Anthony Chow
The Journal of Infectious Diseases, 2001
View PDFchevron_right
In Silico Evaluation of a Mutant Toxic Shock Syndrome Toxin-1 (TSST-1) of Staphylococcus aureus as a Putative Vaccine Candidate
Vaccine Research
Pasteur Institute of Iran, 2020
View PDFchevron_right
Inhibition of Staphylococcal Enterotoxin B-Induced Lymphocyte Proliferation and Tumor Necrosis Factor Alpha Secretion by MAb5, an Anti-Toxic Shock Syndrome Toxin 1 Monoclonal Antibody
Anthony Chow
Infection and Immunity, 2000
View PDFchevron_right
Human scFvs That Counteract Bioactivities of Staphylococcus aureus TSST-1
Wanpen Chaicumpa
Toxins, 2017
View PDFchevron_right
Role of a carboxy-terminal site of toxic shock syndrome toxin 1 in eliciting immune responses of human peripheral blood mononuclear cells
Brigitte König
Infection and Immunity
View PDFchevron_right
Detection and quantitation of toxic shock syndrome toxin 1 in vitro and in vivo by noncompetitive enzyme-linked immunosorbent assay
Karen Bartlett
Journal of Clinical Microbiology, 1987
View PDFchevron_right
Superantigenic activity of toxic shock syndrome toxin-1 is resistant to heating and digestive enzymes
Edward Maina
Journal of Applied Microbiology, 2011
View PDFchevron_right
Double mutant and formaldehyde inactivated TSST-1 as vaccine candidates for TSST-1-induced toxic shock syndrome
Vojtech Thon
Vaccine, 2002
View PDFchevron_right
Application of a Chimeric Protein Construct having Enterotoxin B and Toxic Shock Syndrome Toxin Domains of S. aureus in Immunodiagnostics
Shylaja Ramlal
Indian Journal of Microbiology, 2012
View PDFchevron_right
Staphylococcal toxic shock toxin specifically binds to cultured human epithelial cells and is rapidly internalized
Hector MacDonald
Infection and Immunity, 1984
View PDFchevron_right
Generation, characterization, and epitope mapping of neutralizing and protective monoclonal antibodies against staphylococcal enterotoxin B-induced lethal shock
Avanish Varshney
2011
View PDFchevron_right
Toxic Shock Syndrome Toxin-1-Mediated Toxicity Inhibited by Neutralizing Antibodies Late in the Course of Continual in Vivo and in Vitro Exposure
Martha Eibl
Toxins, 2014
View PDFchevron_right
Crystal structure of a biologically inactive mutant of toxic shock syndrome toxin-1 at 2.5 A resolution
Conrad P Quinn
Protein Science, 1996
View PDFchevron_right
Identification of MHC Class II-Associated Peptides That Promote the Presentation of Toxic Shock Syndrome Toxin-1 to T Cells
David Woodland , Sherri Surman
The Journal of Immunology, 2001
View PDFchevron_right
Monoclonal antibodies protect from Staphylococcal Enterotoxin K (SEK) induced toxic shock and sepsis by USA300 Staphylococcus aureus
jorge Aguilar
Virulence, 2016
View PDFchevron_right
Superantigen Vaccines: A Comparative Study of Genetically Attenuated Receptor-Binding Mutants of Staphylococcal Enterotoxin A
Beverly Dyas
Journal of Infectious Diseases, 1996
View PDFchevron_right
Synthetic Human Monoclonal Antibodies toward Staphylococcal Enterotoxin B (SEB) Protective against Toxic Shock Syndrome
Eric Stavale , H. Karauzum
Journal of Biological Chemistry, 2012
View PDFchevron_right
egc-Encoded Superantigens from Staphylococcus aureus Are Neutralized by Human Sera Much Less Efficiently than Are Classical Staphylococcal Enterotoxins or Toxic Shock Syndrome Toxin
Barbara Bröker
Infection and Immunity, 2004
View PDFchevron_right
THE STAPHYLOCOCCAL TOXIC SHOCK SYNDROME TOXIN 1 TRIGGERS B CELL PROLIFERATION AND DIFFERENTIATION VIA MAJOR HISTOCOMPATIBILITY COMPLEX-UNRESTRICTED COGNATE T/B CELL INTERACTION
ana diaz
View PDFchevron_right
Detection of staphylococcal superantigenic toxins by a CD69-specific cytofluorimetric assay measuring T-cell activation
Timothy Greenland
Journal of clinical microbiology, 1998
View PDFchevron_right
Characterization of a Novel Staphylococcal Enterotoxin-Like Superantigen, a Member of the Group V Subfamily of Pyrogenic Toxins
Paul Orwin
Biochemistry, 2002
View PDFchevron_right
The potential use of toxin antibodies as a strategy for controlling acute Staphylococcus aureus infections
Gordon Cheung
Expert Opinion on Therapeutic Targets, 2012
View PDFchevron_right
TBA225, a fusion toxoid vaccine for protection and broad neutralization of staphylococcal superantigens
Laura Abaandou
Scientific Reports, 2019
View PDFchevron_right
Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1
Hermann Wagner
European Journal of Immunology, 1993
View PDFchevron_right
Colony Immunoblot AssayfortheDetection ofStaphylococcal ToxicShockSyndrome Toxin1(TSST-1) withAnti-TSST-1 F(ab')2 Fragments
Raymond See
1989
View PDFchevron_right
Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome
Gary An
Nature Medicine, 2009
View PDFchevron_right
Bacterial Superantigen Toxins, CD28, and Drug Development
Raymond Kaempfer
Toxins
View PDFchevron_right
Staphylococcal Toxic Shock Syndrome: Mechanisms and Management
Andrew Ferguson , Emma Lappin , Jonathan Silversides
View PDFchevron_right
The Refined Crystal Structure of Toxic Shock Syndrome Toxin-1 at 2.07 Å Resolution
Krishnendu Acharya
Journal of Molecular Biology, 1996
View PDFchevron_right
Defense against biologic warfare with superantigen toxins
Raymond Kaempfer
The Israel Medical Association journal : IMAJ, 2002
View PDFchevron_right
Targeted Proteomics Analysis of Staphylococcal Superantigenic Toxins in Menstrual Fluid from Women with Menstrual Toxic Shock Syndrome (mTSS)
Michel Jaquinod
Toxins
View PDFchevron_right